Bluebird Neurology collaborates with leading pharmaceutical and academic sponsors to conduct FDA-approved clinical trials investigating novel approaches to dementia prevention and treatment, with a particular emphasis on interventions aimed at reversing cognitive symptoms and altering the underlying trajectory of disease. Through this research, eligible patients gain access to emerging therapies and diagnostic technologies not yet available outside of a controlled research setting and are evaluated under the close supervision of our dedicated research team and administered in accordance with rigorous scientific and ethical standards.

Every trial we conduct is designed to advance the broader understanding of cognitive decline while offering our patients a meaningful opportunity to participate in the next generation of dementia care. Participation is always voluntary, thoroughly explained in advance, and reviewed on a case-by-case basis to determine appropriate fit, ensuring that each patient's involvement reflects both clinical suitability and informed personal choice.

We collaborate with leading pharmaceutical and academic sponsors to conduct FDA-approved clinical trials investigating novel approaches to dementia prevention and treatment, with a particular emphasis on interventions aimed at reversing cognitive symptoms and altering the underlying trajectory of disease.

Through this research, eligible patients gain access to emerging therapies and diagnostic technologies not yet available outside of a controlled research setting — evaluated under the close supervision of our dedicated research team and administered in accordance with rigorous scientific and ethical standards.

Every trial we conduct is designed to advance the broader understanding of cognitive decline while offering our patients a meaningful opportunity to participate in the next generation of dementia care. Participation is always voluntary, thoroughly explained in advance, and reviewed on a case-by-case basis to determine appropriate fit, ensuring that each patient's involvement reflects both clinical suitability and informed personal choice.